Does triptolide induce lysosomal-mediated apoptosis in human breast cancer cells?

M. E. Messina, Reginald Halaby

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

With breast cancer plaguing the United States as the second leading cause of cancer related deaths amongst women, as well as the adverse effects of current treatment options there is a need to develop safer and noninvasive treatments. Triptolide is an extract from the herb Tripterygium wilfordii Hook F, and has been used in Chinese medicine for over two centuries and is now used to treat certain autoimmune diseases, such as rheumatoid arthritis. Based on the anti-proliferative, anti-inflammatory, and anti-cancer properties of triptolide we believe that it will stimulate apoptosis in human breast cancer cells. Triptolide is known to induce apoptosis in many cancer cells lines, but the exact mechanisms that regulate this are largely unknown. It has been suggested that triptolide activates the p53 pathway to trigger apoptosis in these cells. However, we believe that there are other mechanisms at work including the activation of lysosomal-mediated apoptosis.

Original languageEnglish
Pages (from-to)91-93
Number of pages3
JournalMedical Hypotheses
Volume77
Issue number1
DOIs
StatePublished - 1 Jul 2011

Fingerprint

Apoptosis
Breast Neoplasms
Tripterygium
Neoplasms
Autoimmune Diseases
Rheumatoid Arthritis
Anti-Inflammatory Agents
Medicine
Cell Line
triptolide
Therapeutics

Cite this

@article{f8e9f05c205f49a98f53be1b86c8cbc6,
title = "Does triptolide induce lysosomal-mediated apoptosis in human breast cancer cells?",
abstract = "With breast cancer plaguing the United States as the second leading cause of cancer related deaths amongst women, as well as the adverse effects of current treatment options there is a need to develop safer and noninvasive treatments. Triptolide is an extract from the herb Tripterygium wilfordii Hook F, and has been used in Chinese medicine for over two centuries and is now used to treat certain autoimmune diseases, such as rheumatoid arthritis. Based on the anti-proliferative, anti-inflammatory, and anti-cancer properties of triptolide we believe that it will stimulate apoptosis in human breast cancer cells. Triptolide is known to induce apoptosis in many cancer cells lines, but the exact mechanisms that regulate this are largely unknown. It has been suggested that triptolide activates the p53 pathway to trigger apoptosis in these cells. However, we believe that there are other mechanisms at work including the activation of lysosomal-mediated apoptosis.",
author = "Messina, {M. E.} and Reginald Halaby",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.mehy.2011.03.034",
language = "English",
volume = "77",
pages = "91--93",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "1",

}

Does triptolide induce lysosomal-mediated apoptosis in human breast cancer cells? / Messina, M. E.; Halaby, Reginald.

In: Medical Hypotheses, Vol. 77, No. 1, 01.07.2011, p. 91-93.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Does triptolide induce lysosomal-mediated apoptosis in human breast cancer cells?

AU - Messina, M. E.

AU - Halaby, Reginald

PY - 2011/7/1

Y1 - 2011/7/1

N2 - With breast cancer plaguing the United States as the second leading cause of cancer related deaths amongst women, as well as the adverse effects of current treatment options there is a need to develop safer and noninvasive treatments. Triptolide is an extract from the herb Tripterygium wilfordii Hook F, and has been used in Chinese medicine for over two centuries and is now used to treat certain autoimmune diseases, such as rheumatoid arthritis. Based on the anti-proliferative, anti-inflammatory, and anti-cancer properties of triptolide we believe that it will stimulate apoptosis in human breast cancer cells. Triptolide is known to induce apoptosis in many cancer cells lines, but the exact mechanisms that regulate this are largely unknown. It has been suggested that triptolide activates the p53 pathway to trigger apoptosis in these cells. However, we believe that there are other mechanisms at work including the activation of lysosomal-mediated apoptosis.

AB - With breast cancer plaguing the United States as the second leading cause of cancer related deaths amongst women, as well as the adverse effects of current treatment options there is a need to develop safer and noninvasive treatments. Triptolide is an extract from the herb Tripterygium wilfordii Hook F, and has been used in Chinese medicine for over two centuries and is now used to treat certain autoimmune diseases, such as rheumatoid arthritis. Based on the anti-proliferative, anti-inflammatory, and anti-cancer properties of triptolide we believe that it will stimulate apoptosis in human breast cancer cells. Triptolide is known to induce apoptosis in many cancer cells lines, but the exact mechanisms that regulate this are largely unknown. It has been suggested that triptolide activates the p53 pathway to trigger apoptosis in these cells. However, we believe that there are other mechanisms at work including the activation of lysosomal-mediated apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=79958064970&partnerID=8YFLogxK

U2 - 10.1016/j.mehy.2011.03.034

DO - 10.1016/j.mehy.2011.03.034

M3 - Article

VL - 77

SP - 91

EP - 93

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 1

ER -